Class information for:
Level 1: VALVULOPATHY//DRUG INDUCED VALVULAR DISEASE//ERGOT DERIVED DOPAMINE AGONISTS

Basic class information

ID Publications Average number
of references
Avg. shr. active
ref. in WoS
21207 369 27.8 76%



Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)



ID, lev.
above
Publications Label for level above
772 11635 PULMONARY HYPERTENSION//PULMONARY ARTERIAL HYPERTENSION//CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION

Terms with highest relevance score



Rank Term Type of term Relevance score
(tfidf)
Class's shr.
of term's tot.
occurrences
Shr. of publ.
in class containing
term
Num. of
publ. in
class
1 VALVULOPATHY Author keyword 9 38% 5% 19
2 DRUG INDUCED VALVULAR DISEASE Author keyword 9 83% 1% 5
3 ERGOT DERIVED DOPAMINE AGONISTS Author keyword 9 83% 1% 5
4 5 HYDROXYTRYPTAMINE 2B RECEPTOR Author keyword 6 80% 1% 4
5 PLEUROPULMONARY FIBROSIS Author keyword 6 100% 1% 4
6 CARDIAC VALVULOPATHY Author keyword 4 67% 1% 4
7 GRP HT BRETAGNE OCCIDENTALE Address 4 67% 1% 4
8 ANOREXIGENS Author keyword 4 44% 2% 7
9 PERGOLIDE Author keyword 4 14% 7% 27
10 BENFLUOREX Author keyword 4 27% 3% 12

Web of Science journal categories

Author Key Words



Rank Web of Science journal category Relevance score
(tfidf)
Class's shr.
of term's tot.
occurrences
Shr. of publ.
in class containing
term
Num. of
publ. in
class
LCSH search Wikipedia search
1 VALVULOPATHY 9 38% 5% 19 Search VALVULOPATHY Search VALVULOPATHY
2 DRUG INDUCED VALVULAR DISEASE 9 83% 1% 5 Search DRUG+INDUCED+VALVULAR+DISEASE Search DRUG+INDUCED+VALVULAR+DISEASE
3 ERGOT DERIVED DOPAMINE AGONISTS 9 83% 1% 5 Search ERGOT+DERIVED+DOPAMINE+AGONISTS Search ERGOT+DERIVED+DOPAMINE+AGONISTS
4 5 HYDROXYTRYPTAMINE 2B RECEPTOR 6 80% 1% 4 Search 5+HYDROXYTRYPTAMINE+2B+RECEPTOR Search 5+HYDROXYTRYPTAMINE+2B+RECEPTOR
5 PLEUROPULMONARY FIBROSIS 6 100% 1% 4 Search PLEUROPULMONARY+FIBROSIS Search PLEUROPULMONARY+FIBROSIS
6 CARDIAC VALVULOPATHY 4 67% 1% 4 Search CARDIAC+VALVULOPATHY Search CARDIAC+VALVULOPATHY
7 ANOREXIGENS 4 44% 2% 7 Search ANOREXIGENS Search ANOREXIGENS
8 PERGOLIDE 4 14% 7% 27 Search PERGOLIDE Search PERGOLIDE
9 BENFLUOREX 4 27% 3% 12 Search BENFLUOREX Search BENFLUOREX
10 DRUG INDUCED ADVERSE EFFECTS IN LUNG 1 100% 1% 2 Search DRUG+INDUCED+ADVERSE+EFFECTS+IN+LUNG Search DRUG+INDUCED+ADVERSE+EFFECTS+IN+LUNG

Key Words Plus



Rank Web of Science journal category Relevance score
(tfidf)
Class's shr.
of term's tot.
occurrences
Shr. of publ.
in class containing
term
Num. of
publ. in
class
1 VALVULOPATHY 39 68% 9% 34
2 5 HT2B RECEPTORS 28 45% 13% 47
3 APPETITE SUPPRESSANT DRUGS 26 42% 13% 47
4 FENFLURAMINE PHENTERMINE 25 54% 9% 32
5 CARDIAC VALVE REGURGITATION 21 52% 8% 29
6 DERIVATIVE DOPAMINE AGONISTS 18 83% 3% 10
7 VALVE ABNORMALITIES 15 71% 3% 12
8 ERGOTAMINE THERAPY 15 88% 2% 7
9 PLEUROPULMONARY CHANGES 13 69% 3% 11
10 FENFLURAMINE 11 12% 23% 86

Journals

Reviews



Title Publ. year Cit. Active references % act. ref.
to same field
Drug-induced fibrotic valvular heart disease 2009 53 63 67%
Drug-induced valvular heart disease 2013 7 31 94%
Drug-induced valvular heart disease: An update 2013 6 37 97%
Fibrotic heart-valve reactions to dopamine-agonist treatment in Parkinson's disease 2007 90 16 75%
The Risk of Valvular Regurgitation in Patients with Parkinson's Disease Treated with Dopamine Receptor Agonists 2011 11 35 80%
Risk of valvular heart disease associated with the use of dopamine agonists in Parkinson's disease: a systematic review 2009 24 46 61%
Role of echocardiography in toxic heart valvulopathy 2009 11 97 89%
Cabergoline therapy and the risk of cardiac valve regurgitation in patients with hyperprolactinemia: A meta-analysis from clinical studies 2008 16 16 75%
Serotonin receptors and heart valve disease-It was meant 2B 2011 31 119 22%
Serotonergic drugs and valvular heart disease 2009 41 71 27%

Address terms



Rank Address term Relevance score
(tfidf)
Class's shr.
of term's tot.
occurrences
Shr. of publ.
in class containing
term
Num. of
publ.
in class
1 GRP HT BRETAGNE OCCIDENTALE 4 67% 1.1% 4
2 CIC0005 2 44% 1.1% 4
3 POLE CARDIOVASC THORAC 1 38% 0.8% 3
4 ESTABLISHED PROD BUSINESS UNIT 1 100% 0.5% 2
5 USHATE IVAN PENTCHEV 1 100% 0.5% 2
6 LTSI INSERM U642 1 40% 0.5% 2
7 UC LILLE 1 40% 0.5% 2
8 SERV MED INTERNE CARDIOL 1 17% 1.1% 4
9 CATHOL LILLE 1 50% 0.3% 1
10 CIC9023 1 50% 0.3% 1

Related classes at same level (level 1)



Rank Relatedness score Related classes
1 0.0000196917 SIBUTRAMINE//ORLISTAT//ANTIOBESITY DRUGS
2 0.0000114565 DEXFENFLURAMINE//D FENFLURAMINE//FENFLURAMINE
3 0.0000105742 MOTOR FLUCTUATIONS//LEVODOPA//DYSKINESIA
4 0.0000100853 MITRAL ANNULAR CALCIFICATION//CALCIFIC AORTIC VALVE DISEASE//VALVULAR INTERSTITIAL CELLS
5 0.0000094732 MACROPROLACTIN//PROLACTINOMA//HYPERPROLACTINEMIA
6 0.0000069912 RETROPERITONEAL FIBROSIS//IDIOPATHIC RETROPERITONEAL FIBROSIS//RIEDELS THYROIDITIS
7 0.0000060171 MONOCROTALINE//PULMONARY ARTERIAL HYPERTENSION//BMPR2
8 0.0000051642 PULMONARY ARTERIAL HYPERTENSION//TREPROSTINIL//PULMONARY HYPERTENSION
9 0.0000051208 TERGURIDE//ERGOLINE//DOPAMINE D 2 AGONIST
10 0.0000046706 HERITAGE MED 275//JCR LA CP RAT//BENFLUOREX